The results in Figure 10B show that patients with low CYP4B1 expression presented a reduced probability of survival, by 40%, in cervical cancer at about 100 months, lung adenocarcinoma patients did not survive within 120 months, and lung squamous cell carcinoma patients showed reduced survival within 170 months, with HR values were 0.774, 0.863, and 1.17, respectively. This evidence concerns the gene CYP4B1 and squamous cell lung carcinoma.